Hepatitis E Diagnostic Tests Market by Test Types, End Users, Growth Trends and Forecast to 2021

Hepatitis E is a liver disease caused by the hepatitis E virus (HEV), and the infection is found worldwide but most common in developing countries with limited access to essential water, sanitation, hygiene and health services. The commonly used tests for HEV infection include detection of IgM and IgG anti-HEV antibodies and detection of HEV RNA. Diagnosis of hepatitis E infection is usually based on the detection of specific IgM antibodies (ELISA). Additional tests include reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis E virus RNA in blood and/or stool samples, carried out in specialized laboratory facilities. Recently, a test for viral antigen detection in serum has been developed. Although several diagnostic assays for anti-HEV antibodies are available, they have undergone fairly limited testing and often provide discordant results, particularly for IgG antibodies. Improved validation of existing anti-HEV antibody assays or development of new assays with superior performance characteristics is urgently needed.

Browse Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/

The global hepatitis E diagnostic tests market segmentation is based on test type (ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, Others), end users (diagnostic laboratories, hospitals, point-of-care).

The global hepatitis E diagnostic tests market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global hepatitis E diagnostic tests market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global hepatitis E diagnostic tests market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global hepatitis E diagnostic tests market and profiled in this report include Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC, and Primerdesign Ltd.

1. Test Type
1.1. ELISA HEV IgM Test Kits
1.2. ELISA HEV IgG Test Kits
1.3. RT-PCR Test Kits
1.4. Others

2. End Users
2.1. Diagnostic Laboratories
2.2. Hospitals
2.3. Point-of-Care
2.4. Research Centers

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Altana Diagnostics GmbH
4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
4.3. Biokit S.A.
4.4. Dia.Pro - Diagnostic Bioprobes s.r.l
4.5. F. Hoffmann-La Roche Ltd.
4.6. Fast-track diagnostics Ltd.
4.7. Fortress Diagnostics Limited
4.8. Mikrogen GmBH
4.9. MP Biomedicals, LLC
4.10. Primerdesign Ltd.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.